Advertisement

STI with Mycoplasma genitalium—more common than Chlamydia trachomatis in patients attending youth clinics in Sweden

  • Peter NolskogEmail author
  • Erik Backhaus
  • Salmir Nasic
  • Helena Enroth
Original Article
  • 274 Downloads

Abstract

The prevalence of Chlamydia trachomatis in Sweden is well known, whereas the prevalence of Mycoplasma genitalium is less well documented. Youth clinics offer free contraception advice, sexually transmitted infection (STI) testing and/or contact tracing for the age group 15–25 years. The main objective of this study was to determine the prevalence of STIs, the presence of symptoms and the role of contact tracing. From July 2013 to March 2014, 1001 persons, 509 women and 492 men, were included in this study of six youth clinics in the Region of Västra Götaland. Symptoms were registered and whether the patient was tested because of contract tracing. Collection of urine samples, testing, treatment and disease registration were performed according to clinical routines. Urine samples were analysed for C. trachomatis/N. gonorrhoeae on the Cobas 4800 system (Roche). M. genitalium was analysed by lab-developed PCR. Genital infection was present in 16.8%. The prevalence of M. genitalium was higher than for C. trachomatis (9.6% and 7.1%). Men with symptoms have a significantly higher relative risk for infection with M. genitalium or C. trachomatis compared to asymptomatic men, while there is no increase for women. Contact tracing is important since positive outcome has a high relative risk for both infections. The prevalence of M. genitalium was higher than C. trachomatis in this study population. Initial testing for both C. trachomatis and M. genitalium should at least be considered for young men presenting with symptoms of genital infection. In finding positive cases, contact tracing is of great importance.

Keywords

STI Mycoplasma genitalium Chlamydia trachomatis Youth clinic Prevalence 

Notes

Acknowledgements

Thanks to Berith Fröberg who collected samples and questionnaire data and compiled the study file. Thanks also to the participating youth clinics Alingsås, Falköping, Lerum, Mariestad, Skara and Skövde, all situated in Västra Götaland, Sweden.

Author’s Contribution

PN initiated the study, applied to the ethics committee and participated in data analysis and writing of the manuscript. EB participated in data analysis and writing of the manuscript. HE participated in planning of the study, reviewed the questionnaire and the ethics application, was responsible for analysis of the study samples, participated in data analysis, writing of the manuscript and applied for funding for the laboratory analyses from Unilabs R&D fund in collaboration with PN. SN performed the statistical analyses of the data and in editing the manuscript.

Compliance with ethical standards

Competing interests

The authors declare that they have no competing interests.

Ethics approval

This study was approved by the Regional ethics committee of Gothenburg, Sweden 2013 (399-13).

Patient consent

Written informed consent was obtained from all study subjects at the youth clinic at the time of inclusion in the study.

References

  1. 1.
    Tully JG, Taylor-Robinson D, Cole RM et al (1981) A newly discovered mycoplasma in the human urogenital tract. Lancet 1(8233):1288–1291CrossRefGoogle Scholar
  2. 2.
    Hjorth SV, Bjornelius E, Lidbrink P et al (2006) Sequence-based typing of Mycoplasma genitalium reveals sexual transmission. J Clin Microbiol 44(6):2078–2083CrossRefGoogle Scholar
  3. 3.
    Daley GM, Russell DB, Tabrizi SN et al (2014) Mycoplasma genitalium: a review. Int J STD AIDS 25(7):475–487CrossRefGoogle Scholar
  4. 4.
    Lis R, Rowhani-Rahbar A, Manhart LE (2015) Mycoplasma genitalium infection and female reproductive tract disease: a meta-analysis. Clin Infect Dis 61(3):418–426CrossRefGoogle Scholar
  5. 5.
    Sweden TPHAo (2017) Public health reporting and statistics. Secondary public health reporting and statistics. https://www.folkhalsomyndigheten.se/the-public-health-agency-of-sweden/public-health-reporting-and-statistics/
  6. 6.
    World Health Organization, Unemo M (2013) Laboratory diagnosis of sexually transmitted infections, including human immunodeficiency virus / edited by Magnus Unemo * [et al] - in IRIS. Geneva: World Health OrganizationGoogle Scholar
  7. 7.
    Fenton KA, Mercer CH, Johnson AM et al (2005) Reported sexually transmitted disease clinic attendance and sexually transmitted infections in Britain: prevalence, risk factors, and proportionate population burden. J Infect Dis 191(Suppl 1):S127–S138CrossRefGoogle Scholar
  8. 8.
    Pereyre S, Laurier Nadalie C, Bebear C et al (2017) Mycoplasma genitalium and Trichomonas vaginalis in France: a point prevalence study in people screened for sexually transmitted diseases. Clin Microbiol Infect 23(2):122 e1–122 e7CrossRefGoogle Scholar
  9. 9.
    Getman D, Jiang A, O'Donnell M et al (2016) Mycoplasma genitalium prevalence, coinfection, and macrolide antibiotic resistance frequency in a multicenter clinical study cohort in the United States. J Clin Microbiol 54(9):2278–2283CrossRefGoogle Scholar
  10. 10.
    Salado-Rasmussen K, Jensen JS (2014) Mycoplasma genitalium testing pattern and macrolide resistance: a Danish nationwide retrospective survey. Clin Infect Dis 59(1):24–30CrossRefGoogle Scholar
  11. 11.
    Batteiger BE, Tu W, Ofner S et al (2010) Repeated chlamydia trachomatis genital infections in adolescent women. J Infect Dis 201(1):42–51CrossRefGoogle Scholar
  12. 12.
    Hosenfeld CB, Workowski KA, Berman S et al (2009) Repeat infection with Chlamydia and gonorrhea among females: a systematic review of the literature. Sex Transm Dis 36(8):478–489CrossRefGoogle Scholar
  13. 13.
    Lau A, Bradshaw CS, Lewis D et al (2015) The efficacy of azithromycin for the treatment of genital mycoplasma genitalium: a systematic review and meta-analysis. Clin Infect Dis 61(9):1389–1399CrossRefGoogle Scholar
  14. 14.
    Manhart LE (2014) Diagnostic and resistance testing for Mycoplasma genitalium: what will it take? Clin Infect Dis 59(1):31–33CrossRefGoogle Scholar
  15. 15.
    Braam JF, van Dommelen L, Henquet CJM et al (2017) Multidrug-resistant Mycoplasma genitalium infections in Europe. Eur J Clin Microbiol Infect Dis 36(9):1565–1567CrossRefGoogle Scholar
  16. 16.
    Gratrix J, Plitt S, Turnbull L et al (2017) Prevalence and antibiotic resistance of Mycoplasma genitalium among STI clinic attendees in Western Canada: a cross-sectional analysis. BMJ Open 7(7):e016300CrossRefGoogle Scholar
  17. 17.
    Munson E (2017) Molecular diagnostics update for the emerging (if not already widespread) sexually transmitted infection agent Mycoplasma genitalium: just about ready for prime time. J Clin Microbiol 55(10):2894–2902CrossRefGoogle Scholar
  18. 18.
    Clarivet B, Picot E, Marchandin H et al (2014) Prevalence of Chlamydia trachomatis, Neisseria gonorrhoeae and Mycoplasma genitalium in asymptomatic patients under 30 years of age screened in a French sexually transmitted infections clinic. Eur J Dermatol 24(5):611–616Google Scholar
  19. 19.
    Hamasuna R, Imai H, Tsukino H et al (2008) Prevalence of Mycoplasma genitalium among female students in vocational schools in Japan. Sex Transm Infect 84(4):303–305CrossRefGoogle Scholar
  20. 20.
    Carre H, Boman J, Osterlund A et al (2008) Improved contact tracing for Chlamydia trachomatis with experienced tracers, tracing for one year back in time and interviewing by phone in remote areas. Sex Transm Infect 84(3):239–242CrossRefGoogle Scholar
  21. 21.
    Sweden] FTPHAo. Sexualitet och hälsa bland unga i Sverige [Sexuality and health among young people in Sweden]. Version 1 ed. Solna, Sweden, 2017:140Google Scholar
  22. 22.
    Sweden] LMPAo. Sexuellt överförbara bakteriella infektioner - behandlingsrekommendation. Uppsala: Läkemedelsverket [Medical Products Agency of Sweden], 2015:22–23Google Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2018

Authors and Affiliations

  1. 1.Department of Communicable Disease Control and Prevention, Region of Västra GötalandSkaraborg HospitalSkövdeSweden
  2. 2.Department of Infectious DiseasesSkaraborg HospitalSkövdeSweden
  3. 3.Research and Development CentreSkaraborg HospitalSkövdeSweden
  4. 4.Clinical molecular microbiology, Laboratory MedicineUnilabsSkövdeSweden
  5. 5.Systems Biology Research Group, School of BiosciencesUniversity of SkövdeSkövdeSweden

Personalised recommendations